http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Reduced Risk of Event-Free Survival Events by 60% and Risk of Death by 50% for Certain Patients with Muscle-Invasive Bladder Cancer W
-
Medome Launches New Medical Industry: Personal Health Intelligence TM - AI-Powered Personal Health Records to Usher In New Era of DIY Healthcare for ALL Americans
-
Masters Of Ring Entertainment Revolutionizes Professional Wrestling Industry with Triple Platform Launch
-
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Ba
-
EXEL reports CABOMETYX reduced disease progression risk by 81% in lung tumors
-
Exelixis Announces Results from Subgroup Analysis of CABINET Phase 3 Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Advanced Lung and Thymic Neuroendocrine Tumors at ESMO 2025
-
Blazpay’s Phase 2 of Crypto Presale Surges With Over $250,000 Raised as XRP and Bitcoin Consolidate
-
Zoomex Announces Argentine Football Star Emiliano Martínez as Its Global Exclusive Brand Ambassador
-
Canadian Securities Exchange Reports September 2025 Performance Figures
-
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.325 PER COMMON SHARE
-
VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.325 PER COMMON SHARE
-
New Break Increases Moray Property Position Through Acquisition and Staking
-
Ethema Files Q1 2025 Quarterly Results
-
Parent Project Muscular Dystrophy Celebrates 20th Annual Sam's Night Event, Marks Two Decades of Community Impact, Growth, and Hope for Families Living with Duchenne
-
Crypto Alert: Blazpay Phase 2 Presale Live at $0.0075 Amid XRP and ETH Market Strength
-
BROAD ARROW’S WYNN LAS VEGAS AUCTION FEATURES SOUGHT-AFTER CARS FOR EVERY COLLECTOR’S TASTE
-
Citi Appointed as Depositary Bank for POMDOCTOR LIMITED’s ADR Program
-
Blazpay’s Crypto Presale Phase 1 Ends in Next 24 Hours as XRP and Solana Face Market Turbulence
-
RAMSAY SANTE : annual results at the end of June 2025
-
UpWeGo Officially Launches its New Driven Meme Coin with the Slogan The Only Way is Up for this Community
-
AmeraMex Secures $622,000 in Equipment Orders
-
CLPS Incorporation Reports Financial Results for the Second Half and Full Year of Fiscal 2025
-
Becky G and Garnier Celebrate Hispanic Heritage Month with Free Block Party in Downtown Los Angeles
-
Montefiore Einstein and Dandelion Partner to Accelerate AI-Driven Drug Development and New Clinical Care Solutions
-
AbbVie completes acquisition of Gilgamesh's depression drug bretisilocin
-
AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin
-
Dialogue AI Closes $6M Seed Round to Bring Live, AI-led Customer Research to Every Team
-
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Vystar’s Vytex® Cloud Bed-in-a-Box Available for Sale
-
Family-Owned Danish Brand Sees Explosive U.S. Growth - Without Outside Investors
-
Novartis Kisqali® 5-year NATALEE data demonstrate 28% reduction in risk of recurrence in the broadest early breast cancer patient population
-
DeFi Technologies to Attend the 2025 Maxim Growth Summit
-
MAX Power Selects Premier Drilling Contractor for Canada’s First Dedicated Natural Hydrogen Well
-
MEXQuick Showcases AI-Driven Market making Technology at TOKEN2049 Singapore Summit
-
Expro Celebrates Success at the 2025 Gulf Energy Awards in Houston
-
ZENITH BANK PLC WINS BIG AT GLOBAL BRANDS AWARDS 2025
-
Gibson Garage Miami - The Ultimate Guitar Experience - To Open in Miami, Spring 2026
-
Eledon Pharmaceuticals to present kidney transplant trial results at medical meeting
-
Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annu
-
Abitibi Metals Expands B26 Mineralization: 150m Step-Out Confirms Continued Growth in the Western Down-Plunge
-
Bonterra Energy Corp. Announces Participation in the Schachter Catch the Energy Conference
-
Novartis Scemblix® receives positive CHMP opinion for the treatment of adults with newly diagnosed CML
-
WNS Announces Closing of Acquisition by Capgemini
-
TOKYOPOP Titles Now Available on MangaPlaza
-
Blazpay’s Crypto Presale Phase 1 Crosses $227K With Less Than Two Days Remaining, Solana and BNB Lead Weekly Gains
-
Driven Tech Honored as a CRN Triple Crown Award Winner for 2025
-
27 Greenberg Traurig Lawyers and 10 Practices Recognised in Chambers UK Legal Guide 2026
-
Benton Closes $1.9 Million Financing
-
Kumo Wins Fast Company's Next Big Things in Tech Award for Advancing AI on Enterprise Data

